ERK1/2 (extracellular-signal-regulated kinase 1/2) MAPKs (mitogen-activated protein kinases) are tightly regulated by the cellular microenvironment in which they operate. Mxi2 is a p38α splice isoform capable of binding to ERK1/2 and ensuring their translocation to the nucleus. Therein Mxi2 sustains ERK1/2 phosphorylation levels and, as a consequence, ERK1/2 nuclear signals are enhanced. However, the molecular mechanisms underlying this process are still unclear. In the present study, we show that Mxi2 prevents nuclear but not cytoplasmic phosphatases from binding to and dephosphorylating ERK1/2, disclosing an unprecedented mechanism for the spatial regulation of ERK1/2 activation. We also demonstrate that the kinetics of ERK1/2 extranuclear signals can be significantly altered by artificially tethering Mxi2 to the cytoplasm. In this case, Mxi2 abolishes ERK1/2 inactivation by cytoplasmic phosphatases and potentiates ERK1/2 functions at this compartment. These results highlight Mxi2 as a key spatial regulator of ERK1/2 functions, playing a pivotal role in the balance between ERK1/2 nuclear and cytoplasmic signals.
Skip Nav Destination
Article navigation
January 2012
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
December 21 2011
Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases
Berta Casar;
Berta Casar
*Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC) - IDICAN - Universidad de Cantabria, Santander 39011, Cantabria, Spain
†Departamento de Biología Molecular, Facultad de Medicina, Santander 39011, Cantabria, Spain
Search for other works by this author on:
Javier Rodríguez;
Javier Rodríguez
*Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC) - IDICAN - Universidad de Cantabria, Santander 39011, Cantabria, Spain
†Departamento de Biología Molecular, Facultad de Medicina, Santander 39011, Cantabria, Spain
Search for other works by this author on:
Gilad Gibor;
Gilad Gibor
‡Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel
Search for other works by this author on:
Rony Seger;
Rony Seger
‡Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel
Search for other works by this author on:
Piero Crespo
Piero Crespo
1
*Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC) - IDICAN - Universidad de Cantabria, Santander 39011, Cantabria, Spain
†Departamento de Biología Molecular, Facultad de Medicina, Santander 39011, Cantabria, Spain
1To whom correspondence should be addressed (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 16 2011
Revision Received:
September 08 2011
Accepted:
September 27 2011
Accepted Manuscript online:
September 27 2011
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2012 Biochemical Society
2012
Biochem J (2012) 441 (2): 571–578.
Article history
Received:
May 16 2011
Revision Received:
September 08 2011
Accepted:
September 27 2011
Accepted Manuscript online:
September 27 2011
Citation
Berta Casar, Javier Rodríguez, Gilad Gibor, Rony Seger, Piero Crespo; Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases. Biochem J 15 January 2012; 441 (2): 571–578. doi: https://doi.org/10.1042/BJ20110870
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.